Akoya Biosciences Inc (AKYA)
2.86
+0.15
(+5.54%)
USD |
NASDAQ |
Sep 27, 16:00
2.86
0.00 (0.00%)
Pre-Market: 20:00
Akoya Biosciences Research and Development Expense (Annual): 21.89M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.89M |
| December 31, 2022 | 23.21M |
| December 31, 2021 | 15.70M |
| Date | Value |
|---|---|
| December 31, 2020 | 9.603M |
| December 31, 2019 | 8.761M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
8.761M
Minimum
2019
23.21M
Maximum
2022
15.83M
Average
15.70M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |
| Bionano Genomics Inc | 54.03M |
| Singular Genomics Systems Inc | 47.76M |